State Street Corp Sangamo Therapeutics, Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, State Street Corp holds 1,122,944 shares of SGMO stock, worth $539,013. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,122,944

Previous 5,019,035 77.63%

Holding current value

$539,013

Previous $5.12 Million 85.52%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.66 - $1.37 $2.57 Million - $5.34 Million	-3,896,091 Reduced 77.63%	1,122,944 $741,000
Q4 2024 Feb 14, 2025	BUY	$0.78 - $2.87 $3.4 Million - $12.5 Million	4,354,414 Added 655.17%	5,019,035 $5.12 Million
Q3 2024 Nov 14, 2024	BUY	$0.32 - $1.1 $46,528 - $159,940	145,400 Added 28.0%	664,621 $571,000
Q2 2024 Aug 14, 2024	SELL	$0.36 - $0.65 $803,729 - $1.45 Million	-2,232,583 Reduced 81.13%	519,221 $186,000
Q1 2024 May 15, 2024	BUY	$0.42 - $1.38 $18,243 - $59,941	43,436 Added 1.6%	2,751,804 $1.84 Million
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $6,684 - $14,038	22,283 Added 0.83%	2,708,368 $1.46 Million
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $17,665 - $44,773	30,458 Added 1.15%	2,686,085 $1.61 Million
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $7 Million - $11 Million	-6,304,951 Reduced 70.36%	2,655,627 $3.45 Million
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $1.37 Million - $3.04 Million	-828,306 Reduced 8.46%	8,960,578 $15.8 Million
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $7.81 Million - $14.3 Million	2,820,608 Added 40.48%	9,788,884 $30.7 Million
Q3 2022 Nov 15, 2022	SELL	$4.27 - $6.39 $3.29 Million - $4.93 Million	-771,195 Reduced 9.96%	6,968,276 $34.1 Million
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $117,607 - $222,665	-35,856 Reduced 0.46%	7,739,471 $32 Million
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $8.21 Million - $12.3 Million	1,570,740 Added 25.32%	7,775,327 $45.2 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $2.44 Million - $3.67 Million	334,832 Added 5.7%	6,204,587 $46.5 Million
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $1.12 Million - $1.49 Million	-124,411 Reduced 2.08%	5,869,755 $52.9 Million
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $5.58 Million - $6.93 Million	-548,501 Reduced 8.38%	5,994,166 $71.8 Million
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $1.8 Million - $2.82 Million	165,610 Added 2.6%	6,542,667 $82 Million
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $5.98 Million - $11.8 Million	-648,110 Reduced 9.23%	6,377,057 $99.5 Million
Q3 2020 Nov 10, 2020	BUY	$9.38 - $12.48 $5.03 Million - $6.69 Million	536,249 Added 8.26%	7,025,167 $66.4 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $10.2 Million - $19.4 Million	1,641,150 Added 33.85%	6,488,918 $58.1 Million
Q1 2020 May 11, 2020	BUY	$5.05 - $8.85 $24.5 Million - $42.9 Million	4,847,768 New	4,847,768 $30.9 Million

Others Institutions Holding SGMO

# of Institutions

139

Shares Held

52.3M

Call Options Held

2.22M

Put Options Held

1.82M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $75.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Sangamo Therapeutics, Inc Transaction History